Altamira Therapeutics .(CYTO)

Search documents
Altamira Therapeutics .(CYTO) - 2019 Q2 - Earnings Call Transcript
2019-08-15 15:36
Auris Medical Holding Ltd. (EARS) Q2 2019 Results Earnings Conference Call August 15, 2019 8:00 AM ET Company Participants Thomas Meyer - CEO Hernan Levett - CFO Conference Call Participants Operator Good morning, and welcome to Auris Medical's Conference Call. On today's call, Thomas Meyer, Auris Medical's Chairman and Chief Executive Officer and Hernan Levett, Auris Medical's Chief Financial Officer will present the company's Financial Results for the First Half 2019 and provide a business update. The acc ...
Altamira Therapeutics .(CYTO) - 2018 Q4 - Annual Report
2019-03-14 21:07
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended December 31, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ OR o SHE ...
Altamira Therapeutics .(CYTO) - 2018 Q4 - Earnings Call Transcript
2019-03-14 14:53
Auris Medical Holding AG (EARS) Q4 2018 Earnings Conference Call March 14, 2019 8:00 AM ET Company Participants Thomas Meyer - CEO Hernan Levett - CFO Conference Call Participants Jim Molloy - AGP Briana Warschun - Edison Group Operator Good morning, and welcome to Auris Medical's Conference Call. On today's call, Thomas Meyer, Auris Medical's Chairman and Chief Executive Officer and Hernan Levett, Auris Medical's Chief Financial Officer will present the company's financial results for the Fourth Quarter an ...
Altamira Therapeutics .(CYTO) - 2018 Q4 - Earnings Call Presentation
2019-03-14 13:53
Innovative Treatments for Inner Ear Disorders 4th Quarter 2018 Financial Results & Business Update March 14, 2019 NASDAQ: EARS Forward-looking Statements This presentation and the accompanying oral commentary may contain statements may contain statements that constitute "forwardlooking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are statements other than historical facts and may include stateme ...